The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis

Arthritis and Rheumatism

Volumn 50, Issue 11, 2004, Pages 3516-3525

  Carbone, Laura D ^a,i,j,k,l   Nevitt, Michael C ^b   Wildy, Kathryn ^c   Barrow, Karen D ^a   Harris, Fran ^b,i,l   Felson, David ^d   Peterfy, Charles ^e   Visser, Marjolein ^f   Harris, Tamara B ^g   Wang, Benjamin W E ^a,j,l   Kritchevsky, Stephen B ^h  

^a Univ of TN Health Sciences Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SYNARC INC   (United States)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g National Institute of Aging   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ Eli Lilly ^*

^j Aventis   (United States)

^k PFIZER INC   (United States)

^l MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; RALOXIFENE; THIAZIDE DIURETIC AGENT;

ARTICLE; BONE LESION; BONE MARROW; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG USE; EDEMA; FEMALE; HUMAN; INTERVIEW; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PAIN ASSESSMENT; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; ALENDRONATE; ARTHROGRAPHY; BONE RESORPTION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ESTROGENS; FEMALE; HUMANS; KNEE; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS, KNEE; PAIN; SEVERITY OF ILLNESS INDEX;

EID: 8444242547     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20627     Document Type: Article

References (64)

1. Forman MD, Malamet R, Kaplan D. A survey of osteoarthritis of the knee in the elderly. J Rheumatol 1983;10:282-7.
2. Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I): evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 1988;128:179-89.
3. Wilson MG, May DS, Kelly JJ. Racial differences in the use of total knee arthroplasty for osteoarthritis among older Americans. Ethn Dis 1994;4:57-67.
4. Quam JP, Michet CJ Jr, Wilson MG, Rand JA, Ilstrup DM, Melton LJ 3rd, et al. Total knee arthroplasty: a population-based study. Mayo Clin Proc 1991;66:589-95.
5. Bailey AJ, Buckland-Wright C, Metz D. The role of bone in osteoarthritis. Age Ageing 2001;30:374-8.
6. Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 2002;61:530-3.
7. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003;48:3130-9.
8. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000;15:1398-404.
9. Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford Study. Arthritis Rheum 2002;46:3178-84.
10. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema and its relation to progressive knee osteoarthritis. Ann Intern Med 2003;139:330-6.
11. Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, et al. The association of bone marrow lesions with pain in knee OA. Ann Intern Med 2001;134:541-9.
12. Guermazi A, Zaim S, Taouli B, Miaux Y, Peterfy CG, Genant HG. MR findings in knee osteoarthritis. Eur Radiol 2003;13:1370-86.
13. Matsui H, Shimizu M, Tsuji H. Cartilage and subchondral bone interaction in osteoarthrosis of human knee joint: a histological and histomorphometric study. Microsc Res Tech 1997;37:333-42.
14. Sabokbar A, Crawford R, Murray DW, Athanasou NA. Macrophage-osteoclast differentiation and bone resorption in osteoarthrotic subchondral acetabular cysts. Acta Orthop Scand 2000;71:255-61.
15. Haynes MK, Hume EL, Smith JB. Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 2002;105:315-25.
16. Cuzzocrea S, Mazzon E, Dugo L, Genovese T, Di Paola R, Ruggeri Z, et al. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 2003;144:1098-107.
17. Flora L. Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum 1979;22:340-6.
18. Frith JC, Monkkonen J, Auriola S, Monkkonen H, Rogers MJ. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum 2001;44:2201-10.
19. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 2001;60:332-6.
20. Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R, Wilson PW, et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998;41:1867-73.
21. Spector TD, Nandra D, Hart DJ, Doyle DV. Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 1997;56:432-4.
22. Nevitt MC, Cummings SR, Lane NE, Hochberg MC, Scott JC, Pressman AR, et al, for the Study of Osteoporotic Fractures Research Group. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Arch Intern Med 1996;156:2073-80.
23. Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 1998;10:269-72.
24. Erb A, Brenner H, Gunther KP, Sturmer T. Hormone replacement therapy and patterns of osteoarthritis: baseline data from the Ulm Osteoarthritis Study. Ann Rheum Dis 2000;59:105-9.
25. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis Study. Arthritis Rheum 1990;33:525-32.
26. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 1999;42:17-24.
27. Buckland-Wright C, Cline G, Meyer J. Structural progression in knee osteoarthritis over 12 months [abstract). Arthritis Rheum 2003;48 Suppl 9:S486.
28. Spector TD, Conaghan P, Buckland-Wright JC, Cline GC, Beary JF, Meyer JM. Risedronate produces disease modification and symptomatic benefit in the treatment of knee osteoarthritis: results from the BRISK Study [abstract]. Arthritis Rheum 2003;48:LB20.
29. Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, Negendank WG. MR features of osteoarthritis of the knee. Magn Reson Imaging 1994;12:703-9.
30. Wluka AE, Wolfe R, Davis SR, Stuckey S, Cicuttini FM. Tibial cartilage volume change in healthy postmenopausal women: a longitudinal study. Ann Rheum Dis 2004;63:444-9.
31. Cicuttini FM, Wluka AE, Wang Y, Stuckey SL, Davis SR. Effect of estrogen replacement therapy on patella cartilage in healthy women. Clin Exp Rheumatol 2003;21:79-82.
32. Bellamy N. WOMAC Osteoarthritis Index: a user's guide. London, Ontario: University of Western Ontario; 1995.
33. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994;10:405-11.
34. Peterfy C, Li J, Zaim S, Duryea J, Lynch J, Miaux Y, et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol 2003;32:128-32.
35. Buckland-Wright C. Evaluation of disease progression during nonsteroidal anti-inflammatory drug treatment: imaging X-rays. Osteoarthritis Cartilage 1999;7:343-4.
36. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
37. Felson DT, McAlindon TE, Anderson JJ, Naimark A, Weissman BW, Aliabadi P, et al. Defining radiographic osteoarthritis for the whole knee. Osteoarthritis Cartilage 1997;5:241-50.
38. Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004;12:177-90.
39. Fleiss JL. The design and analysis of clinic experiments. New York: Wiley; 1986.
40. Lufkin EG, Sarkar S, Kulkarni PM, Ciaccia AV, Siddhanti S, Stock J, et al. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista Alendronate Comparison (EVA) trial. Curr Med Res Opin 2004;20:351-7.
41. Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF. Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 2000;43:2081-90.
42. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors α and β in human articular chondrocytes. Osteoarthritis Cartilage 1999;7:560-6.
43. Claassen H, Hassenpflug J, Schunke M, Sierralta W, Thole H, Kurz B. Immunohistochemical detection of estrogen receptor α in articular chondrocytes from cows, pigs and humans: in situ and in vitro results. Ann Anat 2001;183:223-7.
44. Rosner IA, Goldberg VM, Moskowitz RW. Estrogens and osteoarthritis. Clin Orthop 1986;213:77-83.
45. Hill CI, Gale DG, Chaisson CE, Skinner K, Kazis L, Gale ME, et al. Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001;28:1330-7.
46. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study. Circulation 1999;100:717-22.
47. Cushman M, Meilahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy RP. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 1999;19:893-9.
48. Cushman M, Costantino JP, Tracy RP, Song K, Buckley L, Roberts JD, et al. Tamoxifen and cardiac risk factors in healthy women: suggestion of an anti-inflammatory effect. Arterioscler Thromb Vasc Biol 2001;21:255-61.
49. Cocco R, Tofi C, Fioravanti A, Nerucci F, Nannipieri F, Zampieri A, et al. Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis. Boll Soc Ital Biol Sper 1999;75:71-6.
50. McAlindon TE, Snow S, Cooper C, Dieppe PA. Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis 1992;51:844-9.
51. Cicuttini FM, Spector T, Baker J. Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee. J Rheumatol 1997;24:1164-7.
52. Peterfy CG. Role of MR imaging in clinical research studies. Semin Musculoskelet Radiol 2001;5:365-78.
53. Martel-Pelletier J, Raynauld JP, Pelletier JP. Quantitative imaging of the structural changes of osteoarthritis: an exciting challenge for the new millennium. Curr Rheumatol Rep 2001;3:465-6.
54. Pessis E, Drape JL, Ravaud P, Chevrot A, Dougados M, Ayral X. Assessment of progression in knee osteoarthritis: results of a 1 year study comparing arthroscopy and MRI. Osteoarthritis Cartilage 2003;11:361-9.
55. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330-6.
56. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004;50:1193-206.
57. Link TM, Steinbach LS, Ghosh S, Ries M, Lu Y, Lane N, et al. Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology 2003;226:373-81.
58. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 2001;45:453-61.
59. Jinks C, Jordan K, Croft P. Measuring the population impact of knee pain and disability with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Pain 2002;100:55-64.
60. Nevitt MC, Felson DT, Williams EN, Grady D. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: the Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2001;44:811-8.
61. Saviola G, Santoro L. Clodronate in erosive osteoarthrosis of the hand: efficacy for pain and function recovery. G Ital Med Lav Ergon 2000;22:328-31.
62. Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y. Analgesic effect of etidronate on degenerative joint disease. J Bone Miner Metab 2001;19:251-6.
63. Naganathan V, Zochling J, March L, Sambrook PN. Peak bone mass is increased in the hip in daughters of women with osteoarthritis. Bone 2002;30:287-92.
64. Stewart A, Black AJ. Bone mineral density in osteoarthritis. Curr Opin Rheumatol 2000;12:464-7.